Sitagliptin Prospective study of Intima media thickness Evaluation
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- Acronyms SPIKE
- 01 Jun 2017 Results of prespecified sub-analysis of SPIKE (n=71 sitagliptin group, n=62 conventional group) published in the Diabetes Therapy
- 03 Feb 2016 Status changed from active, no longer recruiting to completed.
- 28 Jan 2016 Primary endpoint has been met.